Swine Parvovirus Disease Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2035

Swine Parvovirus Disease Vaccine Market

The future of the global swine parvovirus disease vaccine market looks promising with opportunities in the sows and boars markets. The global swine parvovirus disease vaccine market is expected to reach an estimated $1,200 million by 2035 from $773 million in 2027 with a CAGR of 5.1% from 2027 to 2035. The major drivers for this market are the rising swine disease outbreaks and the growing global pork consumption.

• Lucintel forecasts that, within the type category, >=107.0 tcid50/ml is expected to witness higher growth over the forecast period due to growing demand for high-efficacy vaccines in large-scale pig farming operations.
• Within the application category, sows is expected to witness the higher growth due to increasing emphasis on biosecurity measures and disease prevention strategies in pig herds.
• In terms of regions, APAC is expected to witness the highest growth over the forecast period due to the large population of commercial pig farming in China and Southeast Asia.

Emerging Trends in Swine Parvovirus Disease Vaccine Market

Technological, regulatory, and market dynamics are rapidly maturing the swine parvovirus disease vaccine market. Different trends are emerging as market players strive to develop novel control approaches for the swine parvovirus disease. As different trends emerge in vaccine development and deployment, players in the value chain must become adept at recognizing and responding to the same.

• Combination Vaccines: An emerging trend is the development and application of combination vaccines. They possess the capability of controlling diseases including swine parvovirus and several others. Combination vaccines have the capability of lowering stress on both farmers and animals. They protect animals from multiple diseases. From a farmer's perspective, combination vaccines offer a greater protective barrier to the animals and reduce the number of vaccinations necessary. This trend will continue to grow.
• Genetic Engineering in Vaccine Development: Market trends based on genetic engineering represent an important area for developing swine parvovirus vaccines. One of these areas focuses on the use of recombinant DNA technology to develop vaccines. Vaccines based on recombinant DNA have the potential to improve the protective capacity of vaccines while decreasing the adverse effects. Genetic engineering can also create vaccines that are more stable and easier to transport to remote areas.
• Preventive Health Methods, Including Vaccination: The swine industry is more concerned about the prevention of health issues. Therefore, health prevention methods, particularly vaccination, are of great interest. In order to help control the spread of diseases, herd management methods are now integrating prevention vaccination. This has been attributed to the increased understanding of the adverse impacts and the costs associated with disease outbreaks, such as the loss of production and the deaths of the animals. Large and small farms have a high interest in the vaccination of swine parvovirus.
• Increased Interest in Affordability and Ease of Use: The demand for vaccines against swine parvovirus is very high in many African and Indian countries. The high demand for affordable vaccines stimulates the innovation of user-friendly swine parvovirus vaccines. Users may include the small holder farmers who do not have the capacity to utilize high level veterinary services. The trend of low cost means low price with improved efficiency is very important. The aim is to improve vaccination of swine diseases in areas were vaccine coverage is low and control of swine diseases is needed most.
• Global Recognition of Swine Disease Prevention: The world's governments are now beginning to understand how vital the prevention of swine diseases is. Thanks to increasing regulatory support, government subsidies, and financial incentivization of farmers, more farmers are deciding to get vaccines. The governments' initiatives to develop policies are also prioritizing the improvement of animal health and welfare, and as a result, farmers are deciding to get swine parvovirus vaccines. Because swine diseases have caused significant economic disruption to so many nations, these regulatory trends take on even greater importance. Government-funded programs to support vaccination are making a vaccination subsidy program a reality for many systems.
• These trends make the swine parvovirus vaccination market more innovative and create better opportunities for financing vaccination. The swine parvovirus vaccination market will see more innovation in disease prevention and control with the use of combination vaccines, genetic engineering, and design to lower prices. The market will experience even greater growth in developing nations due to the regulatory support and focus of preventive health. The future of the swine parvavirus vaccination market is more advanced and better designed to meet the changing and growing needs of the global economy and animal health.

Recent Developments in the Swine Parvovirus Disease Vaccine Market

Technology, growing demand for pork, and government initiatives, have all contributed to recent changes in the swine parvovirus disease vaccine market. Vaccine initiatives help control disease and increase the affordability and accessibility of vaccines, especially in areas where there is a high concentration of pigs. Here are the five main changes in the market in recent years.

• The Use of Combination Vaccines: In recent years, combination vaccines that protect against multiple diseases, including swine parvovirus, have gained a lot of popularity. The use of combination vaccines protects against more diseases than current vaccines and simplifies the number of vaccinations required to protect the herd. As a positive side effect of combination vaccines, animal welfare improves due to a decreased number of necessary injections. The combination of vaccines to protect against diseases such as PRRS (Porcine Reproductive and Respiratory Syndrome) and parvovirus makes it easy for farmers to protect their herd, as a fewer number of injections are required. The market for combination vaccines is growing rapidly due to the prevention of diseases and the promotion of herd immunity.
• Increased Swine Vaccine Production Within China: China, the largest producer of pork, has seen immense growth in domestic swine vaccine production, including parvovirus vaccines. The focus on pork production in China has improved the availability and affordability of vaccines for their large swine farming population. With growing concerns such as outbreaks of African Swine Fever (ASF) and swine parvovirus, there has been a push for growth of vaccine production. This has improved domestic vaccine production and improved pork industry sustainability while protecting from the Rest of the World.
• Use of Recombinant DNA Technology: The use of genetic engineering methods for manufacturing viral antigens has resulted in the development of emerging and more effective recombinant DNA vaccines against swine parvovirus. These vaccines pose no problems of deterioration, thus improve stability and increase the effectiveness of vaccines for a longer period of time. Due to the demand for better and higher efficacious vaccines, recombinant DNA vaccines play a major role for vaccination of novel strains of virus and improving the health status of the herd. This is a significant improvement in the area of vaccine efficacy.
• International Partnerships on Vaccine Design: The development and subsequent relief of the demands of swine parvovirus disease vaccines has been accelerated by partnerships between governments and vaccine manufacturing companies, as well as international research collaborations. This is particularly important for the improvement of veterinary healthcare services in the developing world and other regions with no access to basic veterinary care. Developed countries are helping partnering developing countries to provide more vaccines via the transfer of technology and resources to improve vaccine access. It is expected that ongoing international partnerships will enhance and make more vaccines available.
• Government-Sponsored Vaccine Programs for Farmers in Developing Countries: Several governments have launched vaccine programs for subsidized farmer vaccinations to control the spread of swine parvovirus and other similar diseases. Farm vaccines are intended to cut the financial burden on the smallholder farmers. Swine diseases are endemic to Southeast Asia and the African Sub-continent, but disease control resources are limited. These initiatives are expected to improve vaccine seeking behavior and accelerate the containment of infectious diseases.

New innovations within the domain of the swine parvovirus disease vaccine are driven by the need for effective prevention systems in the international pork market. The development of combination vaccines, Chinese indigenous vaccines as well as recombinant vaccines, configure the new landscape of swine parvovirus vaccines. Within the context of China, government-backed vaccination programs have the potential to reduce the price of vaccines for farmers. Overall, these programs will improve health of animals, enhance food security and stimulate the economy.

Strategic Growth Opportunities in the Swine Parvovirus Disease Vaccine Market

The global market for swine parvovirus disease vaccines is expanding due to the combination of the increased demand for pork and newly available technologies. As an in demand product, prevention of diseases in swine is essential and further adds to the overall market potential. These five key opportunities represent the diversity of market challenges and will drive the future of vaccine development.

• Expanding Vaccine Uptake in Developing Markets: Emerging markets like Asia, Africa and Latin America have high potential for new swine parvovirus disease vaccine sales. Driven primarily by an expanding pork industry, these markets have low levels of investment in disease control. Low-cost vaccines will be the first step for vaccine manufacturers to enter these markets. Governments in these regions must also provide financial support. Ultimately, the expansion of these vaccination programs will lead to increased control of swine disease and lead to greater productivity in global pork production.
• Increased Demand for Combination Vaccines: The demand for combination vaccines aimed at protecting swine from several diseases continues to increase. From an economic perspective, combination vaccines are an attractive option because they lower the costs entailed by time and labor associated with delivering multiple vaccinations. Manufacturing combination vaccines that cover swine parvovirus along with swine PRRS and Erysipelas helps manufacturers fulfill their customers' demands in a cost-effective manner. Farmers will be more inclined to adopt simplified vaccination protocols and also establish herd immunity for their swine populations.
• Technological Innovation in Vaccine Formulations: Development of new technologies with recombinant DNA and adjuvant vaccines creates even more opportunities for growth. These advanced technologies have demonstrated improved safety and, in some cases, improved efficacy over existing technologies. The growing risks of viral mutations increase the demand for vaccines that provide sustained protection against newly emerging and continuously evolving threats. Innovation in this area will create a substantial competitive advantage.
• Increasing Demand for Veterinary Health Services: Increase in global pork production means an increase in demand for veterinary health services for pork production. Veterinary Clinics, pharmaceutical, and livestock service companies create pathways to serve swine producers. Swine producers will create new business opportunities for veterinary service providers, as there is market potential for the subscription-based administration of swine parvovirus disease vaccines combined with comprehensive disease management programs. Veterinary service providers have also begun offering online veterinary consultations and mobile veterinary services to meet the demand for veterinary services in rural and remote areas where there is an absence of veterinary services.
• Government-Funded Disease Control Programs: In many developing nations, especially in developing markets, governments have initiated disease control programs that incorporate swine parvovirus vaccines. These government programs subsidize the cost of vaccines for farmers, and promote vaccination. Along with other animal health and welfare provisions, there is increased pressure for animal health regulations in some key markets, which drives demand for vaccinations for integrated disease prevention programs. This market is predictable as farmers are incentivized to, or mandated to, protect the health of their livestock through vaccinations.

There are many avenues for strategic growth in the swine parvovirus disease vaccine market through the emerging markets, increasing demand for combination vaccines, new technologies, expanding veterinary services, and government-sponsored control programs for animal diseases. Growth in these areas will create more opportunities for improved vaccines, greater accessibility for customers, and higher prevention efforts for diseases. With the growing possibilities, the swine parvovirus vaccine market will focus on innovation and lower cost vaccines to provide better supply of quality vaccines in international markets to meet the growing global pork industry.

Swine Parvovirus Disease Vaccine Market Drivers and Challenges

It is clear that various factors including evolving technologies, economics, and regulations create both opportunities and challenges for the swine parvovirus disease vaccine market. There are more incentives to create swine parvovirus vaccines due to the increased consumption of pork, disease outbreak concerns, the need to maintain herd health in intensive farming systems, and more. However, swine parvovirus disease vaccines also suffer from challenges such as the cost to the farmers, ease of access, and regulatory approval. The focus of this report is on the key drivers and challenges of the swine parvovirus disease vaccine market so that a prediction of how these factors will affect the market in the future can be made.

The factors responsible for driving this market include:

1. Rising Demand for Global Pork: The pork demand increases as the population and income of people in developing countries increase. Since pork is a primary meat for many people, a healthy swine herd is vital to sustaining the supply as outbreaks of swine parvovirus can significantly decrease herd reproductive capacity and financial position of the farmer. There is a market for vaccines that protect herd health and prevent outbreaks. The increasing demand for pork will encourage the adoption of more vaccines.

2. Innovations in Vaccine Technology: The use of the latest technologies, including recombinant DNA vaccines, is a notable addition to the market. Enhanced safety and greater efficacy, as well as more targeted and longer-lasting protection, encourage the adoption of these vaccines. Farmers are more likely to adopt these vaccines in an effort to better protect their animals against swine diseases. Combination swine vaccines are of particular interest as they protect against numerous swine diseases in a single administration. Innovations in vaccine technology and disease control will ultimately lead to greater vaccine adoption.

3. Swine Disease Control and Market Incentives: Many governments in the swine producing countries, namely China, Brazil, and India, are beginning to fund veterinary public health programs to augment their efforts to ensure food security. Financially supporting the public vaccination of swine herds is the primary focus of these legislative acts. Factories are able to maintain and improve the health of their swine herds, substantially improving the overall health of the region, and providing long-term sustainable farmers in the poultry trade. These acts, while increasing the profitability of vaccines, improve overall sustainable growth in the market.

4. Concern Regarding The Health and Welfare of Animals: Growing awareness worldwide regarding the health and welfare of animals is driving demand for vaccines for livestock welfare. Along with the increasing concerns for consumer safety and the ethics of food production, farmers and producers must now meet both the requirements of regulatory agencies and consumer expectations. One of these preventive measures is the swine parvovirus vaccine. Vaccination of pregnant sows will prevent losses of up to 100% of a litter. Therefore, the use of vaccines positively impacts the welfare of animals and the productivity of farms.

5. Increased Veterinary Healthcare and Vaccine Access in Developing Countries: Especially in Asia, Africa and Latin America, healthcare for animals and veterinary vaccines are becoming more readily available in what were previously unserved areas. The growing swine farming practice means an increasing demand for quality and affordable vaccines in these areas. Also, local producers are starting to manufacture vaccines and global partnerships are improving the distribution of vaccines. Also, there is an increasing focus on vaccine initiatives by governments, creating more access to vaccines. In previously underserved areas of veterinary service, the swine parvovirus vaccine is now becoming more available and controls the disease more easily in these areas.

The challenges facing this market include:

1. High Cost and Affordability: Vaccines for developing countries and smaller scale farms in the swine parvovirus disease vaccines market cost a lot of money, which is a major concern. Many farmers may not be willing to purchase vaccines for their herds if they feel the cost is too great. This can lead to increased risk of outbreaks because of insufficient vaccine use. To address these issues, manufacturers should support farming communities by sustaining the costs of vaccines and reducing production costs.

2. Long Regulatory Approval Processes and International Market Entry: Vaccine approval varies greatly across countries. For some, rigorous tests and extensive submission of data are required before approval. For vaccine manufacturers, these regulatory approval processes and differing regulatory systems across international markets lead to complex processes and delays in introducing new vaccines. Regulatory barriers greatly add to the costs associated with vaccine innovation. Regulatory approval processes often require considerable research to better comply, which slows innovation.

3. Vaccine Hesitancy and Public Perception: Some regions are impacted by vaccine hesitancy and a lack of trust that further restricts the adoption of vaccination programs. This can be found in regions where the safety and effectiveness of vaccinations are in question or in places with general discontent and opposition toward government mandated vaccination. Negative public sentiment creates a hostile environment for the impact of public health campaigns. Vaccine hesitancy is especially dangerously contagious. This especially threatens public health, but can also adversely affect the productivity of the swine industry and the herd. This threat can be mitigated through a campaign to educate the public about the importance of vaccinations in public health, as well as the benefits of an individual farm's public health and the productivity of the herd.

There are many factors that drive the growth of the market for swine parvovirus disease vaccines, however, high costs of vaccines, the complexity of regulatory systems, and vaccine hesitancy also shape the market. These drivers include the global demand for pork, the adoption of new technologies in vaccine development, and government funding and support for vaccination programs. High costs and a complex system of regulatory controls impact the availability and affordability of swine parvovirus disease vaccines. There is a need for the vaccination market to grow, support greater adoption of vaccination, and make low cost vaccines available through the simplification of regulatory procedures.

List of Swine Parvovirus Disease Vaccine Market Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies swine parvovirus disease vaccine market companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the swine parvovirus disease vaccine market companies profiled in this report include-

• Merck Animal Health
• Hipra
• Zoetis
• Ceva
• Bioveta
• Boehringer Ingelheim
• Harbin Pharmaceutical Group

Swine Parvovirus Disease Vaccine Market by Segment

The study includes a forecast for the global swine parvovirus disease vaccine market by type, application, and region.

Swine Parvovirus Disease Vaccine Market by Type [Value ($B) from 2019 to 2035]:

• <107.0 Tcid50/ml
• >=107.0 Tcid50/ml

Swine Parvovirus Disease Vaccine Market by Application [Value ($B) from 2019 to 2035]:

• Sows
• Boars

Swine Parvovirus Disease Vaccine Market by Region [Value ($B) from 2019 to 2035]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Swine Parvovirus Disease Vaccine Market

The Swine parvovirus vaccine market is important because of the significant viral infection that impacts swine population reproductive health. Vaccines help stop infections and help maintain the health of pig farms worldwide. There are many drivers of the market that include rising demand of pork, innovations in vaccine technologies, and the improved animal health standards by governments. Below we will cover the recent advancements of the SPV vaccine market in the US, China, Germany, India, and Japan.

• The US: In the US, several factors such as newer and larger commercial pig farms and the use of advanced vaccine systems have boosted the market of swine parvovirus disease vaccines. With these newer vaccines, producers are more focused on achieving herd immunity with the use of both inactivated and modified-live virus vaccines. Innovations of combination vaccines that provide protection from multiple diseases, including SPV, have allowed for improvements in vaccine effectiveness and convenience. The use of newer vaccines in the US has been encouraged by the stronger regulations of animal health.
• China: As the largest pork producer globally, China has begun to implement significant strategies to combat outbreaks of swine diseases, including the use of vaccines for swine parvovirus. Large scale outbreaks of swine diseases have shown the government the importance of prevention and control efforts. Both government initiatives and partnerships with vaccine producers have created cheap, quality vaccines for small and large scale producers. Further, China has started to produce vaccines domestically and has seen going this route improve quality and lower cost for the huge swine farming sector.
• Germany: Some of the more advanced vaccine formulations have begun to be integrated into the German market, including the use of combination vaccines and vaccines designed to combat more novel strains of parvovirus. Animal welfare laws and high standards of production of pork have created a demand for quality disease control products in Germany. The collaboration of veterinary pharmaceutical companies and agricultural associations in Germany have enacted improvements in the adoption of vaccines and disease prevention.
• India: Pig farmers across India continue to grapple with swine parvovirus, and the demand for pork and subsequent demand for pork production is leading to greater interest in vaccines. While India still has a developing swine industry, both the government and private companies are looking for ways to improve and sophisticate vaccination systems. The growing Indian middle class has increased the demand for pork, catapulting an interest in reducing the threats posed to the swine industry from disease. India is experiencing an explosion in better quality, easier to administer vaccines, and as a result, more rural farmers are vaccinating their pigs.
• Japan: The combination of Japan's more advanced veterinary care within the context of their Japanese systems, created the highly developed market for vaccines against swine parvovirus. Japan has a small pork industry which has a high level of specialization and focus; thus, its vaccine industry has the same characteristics. The Japanese vaccine market is changing along with the Rest of the World due to the increase in novel veterinary vaccines. There is an increasing focus on pork farming as a way to improve food safety and animal health and as a result the government is funding vaccine research and production.

Features of the Global Swine Parvovirus Disease Vaccine Market

• Market Size Estimates: swine parvovirus disease vaccine market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2019 to 2026) and forecast (2027 to 2035) by various segments and regions.
• Segmentation Analysis: swine parvovirus disease vaccine market size by type, application, and region in terms of value ($B).
• Regional Analysis: swine parvovirus disease vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the swine parvovirus disease vaccine market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the swine parvovirus disease vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the swine parvovirus disease vaccine market by type (<107.0 tcid50/ml and >=107.0 tcid50/ml), application (sows and boars), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 8 years and what has its impact been on the industry?